LACOSAMIDE

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 68462-697
  • Package NDC 68462-697-30
  • Application number ANDA220268
  • SPL ID bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc
  • SPL set ID bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc
  • UNII 563KS2PQY5
  • RxCUI 809974

What the source publishes

Labeler
GLENMARK PHARMACEUTICALS INC., USA
Active ingredients
LACOSAMIDE
Form
INJECTION, SOLUTION
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:68462-697_bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc
{
  "name": "LACOSAMIDE",
  "splId": "bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc",
  "labels": [
    {
      "setId": "bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "GLENMARK PHARMACEUTICALS INC., USA",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "10 VIAL in 1 CARTON (68462-697-30)  / 20 mL in 1 VIAL (68462-697-20)",
      "package_ndc": "68462-697-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260316"
    }
  ],
  "productId": "68462-697_bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, SOLUTION",
  "productNdc": "68462-697",
  "deaSchedule": "CV",
  "genericName": "LACOSAMIDE",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "LACOSAMIDE",
      "strength": "10 mg/mL"
    }
  ],
  "applicationNumber": "ANDA220268",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20260316",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000008486"
    ],
    "upc": [
      "0368462697207"
    ],
    "unii": [
      "563KS2PQY5"
    ],
    "rxcui": [
      "809974"
    ],
    "spl_set_id": [
      "bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc"
    ],
    "pharm_class_pe": [
      "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
    ],
    "manufacturer_name": [
      "GLENMARK PHARMACEUTICALS INC., USA"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:68462-697_bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc"